Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Treon

Showing results (41-50 of 323) with videos related to

Pageof 33
Sort By:
Hematology/Oncology Clinics of North America|September 13, 2014
Waldenström macroglobulinemiaSteven P Treon, Zachary R Hunter, Jorge J Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?Shayna Sarosiek, Steven P Treon, Andrew R Branagan, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, SwedenSteven P Treon, Christopher J Patterson, Eva Kimby, et al.
Expert Review of Hematology|June 16, 2017
Novel approaches to targeting MYD88 in Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.
Hemasphere|March 21, 2022
Genomic landscape of Waldenström's macroglobulinemiaSteven P Treon, Zachary R Hunter, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Proceedings of the Seventh International Workshop on Waldenström MacroglobulinemiaSteven P Treon, Christopher J Patterson, Nikhil C Munshi, et al.
Seminars in Hematology|May 18, 2023
Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: What we learned, and how it will impact scientific discovery and patient careSteven P Treon, Christopher J Patterson, Ramon Garcia Sanz, et al.
American Journal of Hematology|November 23, 2022
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemiaJorge J Castillo, Christian Buske, Judith Trotman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.
Investigative Ophthalmology & Visual Science|March 11, 2008
Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.
Pageof 33

Showing results (41-50 of 323) with videos related to

Sort By:
Pageof 33
Hematology/Oncology Clinics of North America|September 13, 2014
Waldenström macroglobulinemiaSteven P Treon, Zachary R Hunter, Jorge J Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?Shayna Sarosiek, Steven P Treon, Andrew R Branagan, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, SwedenSteven P Treon, Christopher J Patterson, Eva Kimby, et al.
Expert Review of Hematology|June 16, 2017
Novel approaches to targeting MYD88 in Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.
Hemasphere|March 21, 2022
Genomic landscape of Waldenström's macroglobulinemiaSteven P Treon, Zachary R Hunter, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Proceedings of the Seventh International Workshop on Waldenström MacroglobulinemiaSteven P Treon, Christopher J Patterson, Nikhil C Munshi, et al.
Seminars in Hematology|May 18, 2023
Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: What we learned, and how it will impact scientific discovery and patient careSteven P Treon, Christopher J Patterson, Ramon Garcia Sanz, et al.
American Journal of Hematology|November 23, 2022
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemiaJorge J Castillo, Christian Buske, Judith Trotman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.
Investigative Ophthalmology & Visual Science|March 11, 2008
Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemiaMarcel N Menke, Gilbert T Feke, J Wallace McMeel, et al.
Pageof 33